
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $736.4M | -- | -- | $0.81 | -- |
08/06/2025 | Q2 | $741M | -- | -- | $0.76 | -- |
05/08/2025 | Q1 | $625.9M | $598.1M | $0.54 | $0.74 | -$0.20 |
02/20/2025 | Q4 | $646.2M | $657.3M | $0.19 | $0.75 | -$0.56 |
11/05/2024 | Q3 | $604.8M | $625.7M | $0.38 | $0.65 | -$0.27 |
08/06/2024 | Q2 | $615.4M | $629.7M | $0.23 | $0.68 | -$0.45 |
05/07/2024 | Q1 | $589.6M | $606.7M | -$0.05 | $0.57 | -$0.62 |
02/20/2024 | Q4 | $608.2M | $616.5M | $0.11 | $0.61 | -$0.50 |
11/07/2023 | Q3 | -- | -- | $0.01 | $0.57 | -$0.56 |
08/03/2023 | Q2 | -- | -- | $0.57 | $0.59 | -$0.02 |
05/04/2023 | Q1 | -- | -- | $0.48 | $0.51 | -$0.03 |
02/21/2023 | Q4 | -- | -- | $0.49 | $0.56 | -$0.07 |
11/08/2022 | Q3 | -- | -- | $0.47 | $0.52 | -$0.05 |
08/04/2022 | Q2 | -- | -- | $0.53 | $0.53 | -$0.00 |
05/10/2022 | Q1 | -- | -- | $0.37 | $0.47 | -$0.10 |
02/17/2022 | Q4 | -- | -- | $0.14 | $0.47 | -$0.33 |
11/04/2021 | Q3 | -- | -- | $0.45 | $0.45 | -$0.00 |
08/04/2021 | Q2 | -- | -- | $0.40 | $0.44 | -$0.04 |
05/04/2021 | Q1 | -- | -- | $0.44 | $0.37 | $0.07 |
02/17/2021 | Q4 | -- | -- | $0.52 | $0.51 | $0.01 |
10/28/2020 | Q3 | -- | -- | $0.44 | $0.31 | $0.13 |
08/05/2020 | Q2 | -- | -- | -$0.21 | -$0.11 | -$0.10 |
05/07/2020 | Q1 | -- | -- | $0.25 | $0.38 | -$0.13 |
02/20/2020 | Q4 | -- | -- | $0.44 | $0.52 | -$0.08 |
11/06/2019 | Q3 | -- | -- | $0.38 | $0.42 | -$0.04 |
08/01/2019 | Q2 | -- | -- | $0.41 | $0.41 | $0.00 |
05/02/2019 | Q1 | -- | -- | $0.36 | $0.41 | -$0.05 |
02/21/2019 | Q4 | -- | -- | $0.43 | $0.39 | $0.04 |
11/08/2018 | Q3 | -- | -- | $0.39 | $0.32 | $0.07 |
08/01/2018 | Q2 | -- | -- | $0.44 | $0.35 | $0.09 |
05/02/2018 | Q1 | -- | -- | $0.41 | $0.36 | $0.05 |
02/21/2018 | Q4 | -- | -- | $0.38 | $0.35 | $0.03 |
11/08/2017 | Q3 | -- | -- | $0.30 | $0.30 | $0.00 |
08/02/2017 | Q2 | -- | -- | $0.32 | $0.30 | $0.02 |
05/17/2017 | Q1 | -- | -- | $0.30 | $0.30 | -$0.00 |
02/27/2017 | Q4 | -- | -- | $0.31 | $0.33 | -$0.02 |
11/08/2016 | Q3 | -- | -- | $0.29 | $0.28 | $0.01 |
07/26/2016 | Q2 | -- | -- | $0.29 | $0.28 | $0.01 |
05/03/2016 | Q1 | -- | -- | $0.29 | $0.28 | $0.01 |
02/24/2016 | Q4 | -- | -- | $0.32 | $0.30 | $0.02 |
11/03/2015 | Q3 | -- | -- | $0.28 | $0.25 | $0.03 |
Globus Medical reported $598.1M worth of top line sales in its most recent quarter.
Globus Medical announced earnings per share of $0.54 which represents a miss of analyst forecast a $0.74 per share.
Globus Medical reported $402.7M that represents $2.88 per share over the last quarter.
Globus Medical's earnings are forecast to grow from $0.75 per share to $2.99 per share next year representing an increase of 322.35%.
Globus Medical's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.